2012 Liver resections in the 21st century: We are far from zero mortality

HPB

Volumn 15, Issue 11, 2013, Pages 908-915

  Dokmak, Safi ^a,b   Ftériche, Fadhel Samir ^a,b   Borscheid, René ^a,b   Cauchy, François ^a,b   Farges, Olivier ^a,b   Belghiti, Jacques ^a,b  

^a BEAUJON HOSPITAL   (France)

^b ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN;

ARTICLE; ASCITES; BILE DUCT FISTULA; BILE DUCT STONE; BILE LEAKAGE; BILIARY PERITONITIS; BILIRUBIN BLOOD LEVEL; CHEMOEMBOLIZATION; COLORECTAL LIVER METASTASIS; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; FATTY LIVER; GALLBLADDER CARCINOMA; HIGH RISK PATIENT; HUMAN; LIVER ADENOMA; LIVER BIOPSY; LIVER CANCER; LIVER CELL CARCINOMA; LIVER FAILURE; LIVER FIBROSIS; LIVER FOCAL NODULAR HYPERPLASIA; LIVER HISTOLOGY; LIVER HYDATID CYST; LIVER POLYCYSTIC DISEASE; LIVER RESECTION; MORTALITY; NUCLEAR MAGNETIC RESONANCE IMAGING; RETROSPECTIVE STUDY; ADOLESCENT; ADULT; AGED; ELECTIVE SURGERY; EPIDEMIOLOGY; FEMALE; FRANCE; LIVER DISEASES; MALE; MIDDLE AGED; SURVIVAL RATE; TRENDS; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ELECTIVE SURGICAL PROCEDURES; FEMALE; FRANCE; HEPATECTOMY; HUMANS; LIVER DISEASES; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SURVIVAL RATE; YOUNG ADULT;

EID: 84886087198     PISSN: 1365182X     EISSN: 14772574     Source Type: Journal    
DOI: 10.1111/hpb.12069     Document Type: Article

References (45)

1. Jarnagin WR, Gonen M, Fong Y, DeMatteo RP, Ben-Porat L, Little S, et al. (2002) Improvement in perioperative outcome after hepatic resection. Analysis of 1803 consecutive cases over the past decade. Ann Surg 236: 397-407.
2. Poon RT, Fan ST, Lo CM, Liu CL, Lam CM, Yuen WK, et al. (2004) Improving perioperative outcome expands the role of hepatectomy in management of benign and malignant hepatobiliary diseases. Analysis of 1222 consecutive patients from a prospective database. Ann Surg 240: 698-710.
3. Imamura H, Seyama Y, Kokudo N, Maema A, Sugawara Y, Sano K, et al. (2003) One thousand fifty-six hepatectomies without mortality in 8 years. Arch Surg 138: 1198-1206.
4. Kamiyama T, Nakanishi K, Yokoo H, Kamachi H, Tahara M, Yamashita K, et al. (2010) Perioperative management of hepatic resection toward zero mortality and morbidity: analysis of 793 consecutive cases in a single institution. J Am Coll Surg 211: 443-449.
5. Farges O, Belghiti J, Kianmanesh R, Regimbeau JM, Santoro R, Vilgrain V, et al. (2003) Portal vein embolization before right hepatectomy: prospective clinical trial. Ann Surg 237: 208-217.
6. Mise Y, Hasegawa K, Satou S, Aoki T, Beck Y, Sugawara Y, et al. (2011) Venous reconstruction based on virtual liver resection to avoid congestion in the liver remnant. Br J Surg 98: 1742-1751.
7. Belghiti J, Noun R, Malafosse R, Jagot P, Sauvanet A, Pierangeli F, et al. (1999) Continuous versus intermittent portal trial clamping for liver resection. Ann Surg 229: 369-375.
8. Rubbia-Brandt L, Audard V, Sartoretti P, Roth AD, Brezault C, Le Charpentier M, et al. (2004) Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer. Ann Oncol 15: 460-466.
9. Soubrane O, Brouquet A, Zalinski S, Terris B, Brézault C, Mallet V, et al. (2010) Predicting high grade lesions of sinusoidal obstruction syndrome related to oxaliplatin-based chemotherapy for colorectal liver metastases: correlation with post-hepatectomy outcome. Ann Surg 251: 454-460.
10. Vauthey JN, Pawlik TM, Ribero D, Wu TT, Zorzi D, Hoff PM, et al. (2006) Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol 24: 2065-2072.
11. Cescon M, Vetrone G, Grazi GL, Ramacciato G, Ercolani G, Ravaioli M, et al. (2009) Trends in perioperative outcome after hepatic resection. Analysis of 1500 consecutive unselected cases over 20 years. Ann Surg 249: 995-1002.
12. de Haas RJ, Wicherts DA, Andreani P, Pascal G, Saliba F, Ichai P, et al. (2011) Impact of expanding criteria for resectability of colorectal metastases on short- and longterm outcomes after hepatic resection. Ann Surg 253: 1069-1079.
13. Belghiti J, Hiramatsu K, Benoist S, Massault P, Sauvanet A, Farges O,. (2000) Seven hundred forty-seven hepatectomies in the 1990s: an update to evaluate the actual risk of liver resection. J Am Coll Surg 191: 38-46.
14. Belghiti J, Guevara OA, Noun R, Saldinger PF, Kianmanesh R,. (2001) Liver hanging manoeuvre: a safe approach to right hepatectomy without liver mobilization. J Am Coll Surg 193: 109-111.
15. Bedossa P, Poynard T,. (1996) An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology 24: 289-293.
16. Wicherts DA, de Haas RJ, Sebagh M, Ciacio O, Lévi F, Paule B, et al. (2011) Regenerative nodular hyperplasia of the liver related to chemotherapy: impact on outcome of liver surgery for colorectal metastases. Ann Surg Oncol 18: 659-669.
17. Dindo D, Demartines N, Clavien PA,. (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240: 205-213.
18. Balzan S, Belghiti J, Farges O, Ogata S, Sauvanet A, Delefosse D, et al. (2005) The '50-50' criteria on postoperative day 5. An accurate predictor of liver failure and death after hepatectomy. Ann Surg 242: 824-829.
19. Ishizawa T, Hasegawa K, Kokudo N, Sano K, Imamura H, Beck Y, et al. (2009) Risk factors and management of ascites after liver resection to treat hepatocellular carcinoma. Arch Surg 144: 46-51.
20. Koch M, Garden OJ, Padbury R, Rahbari NN, Adam R, Capussotti L, et al. (2011) Bile leakage after hepatobiliary and pancreatic surgery: a definition and grading of severity by the International Study Group of Liver Surgery. Surgery 149: 680-688.
21. Melloul E, Dondero F, Paugam-Burtz C, Bouadma L, Arnulf B, Belghiti J,. (2009) Living liver donor death related to complications of myeloma. Liver Transpl 15: 326-329.
22. Kneuertz PJ, Marsh JW, de, Jong MC, Covert K, Hyder O, Hirose K, et al. (2012) Improvements in quality of life after surgery for benign hepatic tumours: results from a dual centre analysis. Surgery 152: 193-201.
23. Dokmak S, Paradis V, Vilgrain V, Sauvanet A, Farges O, Valla D, et al. (2009) A single-centre surgical experience of 122 patients with single and multiple hepatocellular adenomas. Gastroenterology 137: 1698-1705.
24. Belghiti J,. (2009) Will improved donor safety increase liver donations? Transplantation 88: 19-20.
25. Organ Procurement and Transplantation Network. (2012) Living donor transplants in the US (1988-2012). Available at http://optn.transplant.hrsa.gov/ latestData/rptData.asp (last accessed 1 October 2012).
26. Menon KV, Al-Mukhtar A, Aldouri A, Prasad RK, Lodge PA, Toogood GJ,. (2006) Outcomes after major hepatectomy in elderly patients. J Am Coll Surg 203: 677-683.
27. Shirabe K, Kajiyama K, Harimoto N, Gion T, Tsujita E, Abe T, et al. (2009) Early outcome following hepatic resection in patients older than 80 years of age. World J Surg 33: 1927-1932.
28. Adam R, Frilling A, Elias D, Laurent C, Ramos E, Capussotti L, et al. (2010) Liver resection of colorectal metastases in elderly patients. Br J Surg 97: 366-376.
29. Bhayani NH, Hyder O, Frederick W, Schulick RD, Wolgang CL, Hirose K, et al. (2012) Effect of metabolic syndrome on perioperative outcomes after liver surgery: a National Surgical Quality Improvement Program (NSQIP) analysis. Surgery 152: 218-226.
30. Vanwagner LB, Bhave M, Te HS, Feinglass J, Alvarez L, Rinella ME,. (2012) Patients transplanted for non-alcoholic steatohepatitis are at increased risk for postoperative cardiovascular events. Hepatology 56: 1741-1750.
31. Laish I, Braun M, Mor E, Sulkes J, Harif Y, Ben Ari Z,. (2011) Metabolic syndrome in liver transplant recipients: prevalence, risk factors, and association with cardiovascular events. Liver Transpl 17: 15-22.
32. de Meijer VE, Kalish BT, Puder M, Ijzermans JN,. (2010) Systematic review and meta-analysis of steatosis as a risk factor in major hepatic resection. Br J Surg 97: 1331-1339.
33. McCormack L, Petrowsky H, Jochum W, Furrer K, Clavien PA,. (2007) Hepatic steatosis is a risk factor for postoperative complications after major hepatectomy: a matched case-control study. Ann Surg 245: 923-930.
34. Kooby DA, Fong Y, Suriawinata A, Gonen M, Allen PJ, Klimstra DS, et al. (2003) Impact of steatosis on perioperative outcome following hepatic resection. J Gastrointest Surg 7: 1034-1044.
35. Reddy SK, Marsh JW, Varley PR, Mock BK, Chopra KB, Geller DA, et al. (2012) Underlying steatohepatitis, but not simple hepatic steatosis, increases morbidity after liver resection: a case-control study. Hepatology 56: 2221-2230.
36. Cauchy F, Zalinski S, Dokmak S, Fuks D, Farges O, Castera L, et al. (2013) Surgical treatment of HCC associated with the metabolic syndrome. Br J Surg 100: 113-121.
37. Farges O, Malassagne B, Flejou JF, Balzan S, Sauvanet A, Belghiti J,. (1999) Risk of major liver resection in patients with underlying chronic liver disease. A reappraisal. Ann Surg 229: 210-215.
38. Imamura H, Matsuyama Y, Miyagawa Y, Ishida K, Shimada R, Miyagawa S, et al. (1999) Prognostic significance of anatomical resection and des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma. Br J Surg 86: 1032-1038.
39. Neuhaus P, Jonas S, Bechstein WO, Lohmann R, Radke C, Kling N, et al. (1999) Extended resections for hilar cholangiocarcinoma. Ann Surg 230: 808-819.
40. Agrawal S, Belghiti J,. (2011) Oncologic resection for malignant tumours of the liver. Ann Surg 253: 656-665.
41. Bachellier P, Rosso E, Pessaux P, Oussoultzoglou E, Nobili C, Panaro F, et al. (2011) Risk factors for liver failure and mortality after hepatectomy associated with portal vein resection. Ann Surg 253: 173-179.
42. Cauchy F, Aussilhou B, Dokmak S, Fuks D, Gaujoux S, Farges O, et al. (2012) Reappraisal of the risks and benefits of major liver resection in patients with initially unresectable colorectal liver metastases. Ann Surg 256: 746-752.
43. Yang T, Zhang J, Lu JH, Yang GS, Wu MC, Yu WF,. (2011) Risk factors influencing postoperative outcomes of major hepatic resection of hepatocellular carcinoma for patients with underlying liver diseases. World J Surg 35: 2073-2082.
44. Sima CS, Jarnagin WR, Fong Y, Elkin E, Fischer M, Wuest D, et al. (2009) Predicting the risk of perioperative transfusion for patients undergoing elective hepatectomy. Ann Surg 250: 914-921.
45. Lam CM, Fan ST, Lo CM, Wong J,. (1999) Major hepatectomy for hepatocellular carcinoma in patients with an unsatisfactory indocyanine green clearance test. Br J Surg 86: 1012-1017.